These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29407134)

  • 21. One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery.
    Chezar-Azerrad C; Musallam A; Shea C; Zhang C; Torguson R; Yerasi C; Case BC; Forrestal BJ; Khalid N; Khan JM; Shlofmitz E; Chen Y; Satler LF; Bernardo NL; Ben-Dor I; Rogers T; Hashim H; Mintz GS; Waksman R
    Am J Cardiol; 2021 Jul; 151():45-50. PubMed ID: 34030883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.
    Mitomo S; Jabbour RJ; Watanabe Y; Mangieri A; Ancona M; Regazzoli D; Tanaka A; Nakajima A; Naganuma T; Giannini F; Latib A; Nakamura S; Colombo A
    Int J Cardiol; 2018 Mar; 254():53-58. PubMed ID: 29407132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stents for ostial coronary stenoses: perspectives on the horizon.
    Leesar MA
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):735-6. PubMed ID: 24167048
    [No Abstract]   [Full Text] [Related]  

  • 24. A new ostial stent positioning system (Ostial Pro) for the accurate placement of stents to treat aorto-ostial lesions.
    Fischell TA; Malhotra S; Khan S
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):353-7. PubMed ID: 18288737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks.
    Beale CE; Dawn Abbott J
    Catheter Cardiovasc Interv; 2017 May; 89(6):992-993. PubMed ID: 28488403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era.
    Rathore S; Kaul U
    Indian Heart J; 2011; 63(3):228-33. PubMed ID: 22734340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus-eluting stents in interventional cardiology.
    Townsend JC; Rideout P; Steinberg DH
    Vasc Health Risk Manag; 2012; 8():393-404. PubMed ID: 22910420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    Bangalore S
    N Engl J Med; 2016 Dec; 375(26):2602-3. PubMed ID: 28032959
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    Vora AN; Rao SV; Stone GW
    N Engl J Med; 2016 Dec; 375(26):2602. PubMed ID: 28032958
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    Farshid A
    N Engl J Med; 2016 Dec; 375(26):2604. PubMed ID: 28029913
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    Urban P; Oldroyd K; Krackhardt F
    N Engl J Med; 2016 Dec; 375(26):2603-4. PubMed ID: 28029912
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    Nordrehaug JE; Wiseth R; Bønaa KH
    N Engl J Med; 2016 Dec; 375(26):2604-2605. PubMed ID: 28029911
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
    Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.
    Park SD; Yoon CH; Oh IY; Suh JW; Cho YS; Youn TJ; Choi DJ; Chae IH
    Trials; 2013 Feb; 14():38. PubMed ID: 23394404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of coronary artery in-stent restenosis.
    Kokkinidis DG; Waldo SW; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2017 Mar; 15(3):191-202. PubMed ID: 28116914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?].
    Matschke K; Tugtekin SM; Kappert U; Jung F; Park JW; Knaut M
    Herz; 2004 Mar; 29(2):201-7. PubMed ID: 15057442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.